GlassScriptPhysician profile
Shlomo Stemmer
NPI 1336234780
$3,153.38
in general payments reported to CMS, 2019-2025
23 companies · $88.15 in 2025
The $88.15 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $314 · 2021: $811 · 2022: $581 · 2023: $481 · 2024: $203 · 2025: $88.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.09 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $980.74 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $478.11 | 2020-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $468.52 | 2023-2025 | Gemtesa, Myfembree |
| Avion Pharmaceuticals | $229.37 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $205.66 | 2019-2022 | |
| Zyla Life Sciences, INC. | $128.64 | 2019-2020 | |
| Amgen INC. | $95.90 | 2019-2021 | |
| Myovant Sciences INC. | $93.88 | 2021-2022 | |
| Evofem Biosciences, INC. | $65.03 | 2021-2022 | |
| Aesculap, INC. | $59.65 | 2019-2020 | |
| Shield Therapeutics INC | $55.27 | 2022-2024 | Accrufer |
| Pfizer INC. | $44.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $44.38 | 2019-2020 | |
| Lupin INC. | $43.11 | 2019 | |
| Daiichi Sankyo INC. | $28.85 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $20.70 | 2021 | |
| Covidien LP | $19.33 | 2019 | |
| Hologic Sales and Service, LLC | $18.84 | 2020 | |
| Hologic INC | $18.71 | 2021 | |
| Millicent US INC | $18.62 | 2025 | Intrarosa |
| Allergan, INC. | $12.37 | 2020 | |
| Mission Pharmacal Company | $11.86 | 2019 | |
| Coopersurgical, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shlomo Stemmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.